How many insider trades does FilingIQ track for ICCM?

FilingIQ tracks 5 Form 4 insider transactions for ICCM (IceCure Medical Ltd.), covering filings from Aug 14, 2026 onwards. 5 of those were filed in the last 90 days.

Are ICCM insiders net buyers or net sellers?

Across the full Form 4 history for ICCM, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ICCM insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ICCM in?

IceCure Medical Ltd. (ICCM) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $11.41M.

ICCM insider trading

NasdaqCM Healthcare

IceCure Medical Ltd. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

0% / 0%

Market cap

$11.41M

About IceCure Medical Ltd.

IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MSense, a multi probe system for the treatment of multiple and larger tumors. The company serves hospitals, interventional radiological centers, ambulatory centers, and private clinics. IceCure Medical Ltd was incorporated in 2006 and is headquartered in Caesarea, Israel.

Company website: www.icecure-medical.com

ICCM insider activity at a glance

FilingIQ has scored 5 insider transactions for ICCM since Aug 14, 2026. The most recent filing in our index is dated Aug 14, 2026.

Across the full history, 0 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

View live ICCM trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 983

UNITED THERAPEUTICS Corp

NUVL 195

Nuvalent, Inc.

KYMR 193

Kymera Therapeutics, Inc.

GH 192

Guardant Health, Inc.

Hims & Hers Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for ICCM?: FilingIQ tracks 5 Form 4 insider transactions for ICCM (IceCure Medical Ltd.), covering filings from Aug 14, 2026 onwards. 5 of those were filed in the last 90 days.
Are ICCM insiders net buyers or net sellers?: Across the full Form 4 history for ICCM, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ICCM insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ICCM in?: IceCure Medical Ltd. (ICCM) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $11.41M.

Methodology & sources

Every ICCM insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.